| Announcements Kathy Uscinski Joins CTO The clinical trials operation for Yale Cancer Center remains one of my top priorities for 2011. Hank Durivage has led our Clinical Trials Office through a host of staff and operational changes needed. In addition to Hank's leadership, I am pleased to announce that Kathleen Uscinski joined Yale Cancer Center and the Yale Center for Clinical Investigation as the Associate Director for Clinical Trials Operations.
Kathy was most recently the Director of the Office of Human Research Protection for Yale School of Medicine and has already hit the ground running with her leadership of operations in the CTO. Hank will continue as the Associate Director for Clinical Trials and Regulatory Affairs. Please join me in welcoming Kathy to the leadership team.
Closer to Free Bike Ride Please join your colleagues from Yale Cancer Center and Smilow Cancer Hospital for our first annual Closer to Free Bike Ride on September 10, 2011. The 25- or 100-mile ride will depart from the Yale Bowl. This is the premier fundraising event to support our cancer care and research efforts. I will be riding with my family, and look forward to seeing many teams of riders from Smilow and Yale. Registration is now open online.
Learn More >> |
Smilow Cancer Hospital Options for Robotic Surgery Expand Dr. Charles Cha performed the first robotic distal pancreatectomy/splenectomy for a neuroendocrine tumor at Smilow Cancer Hospital last week. The patient recovered from the operation very well and was able to go home in three days. Robotic surgery is available at Smilow Cancer Hospital for appropriate patients diagnosed with prostate cancer or gynecological malignancies. Dr. Cha's experience will allow us to expand our robotic surgery program to some patients with gastrointestinal malignancies.
Advanced Vascular Imaging Services Available Smilow Cancer Hospital is now offering full service non-invasive vascular ultrasound and physiological testing on the second floor of the hospital in the diagnostic imaging suites. Led by Leslie Scoutt, MD, screening for varicose veins, venous insufficiency, carotid ultrasound, transcranial doppler aortic aneurysms, renal artery stenosis, lower and upper arterial bypass grafts, dialysis access transplant, hepatic/TIPS, portal, mesenteric vascular imaging, lower and upper venous Doppler for DVT, vein mapping, and segmental pressure ABI/PVR is available. To schedule a patient exam, please call (203) 688-2433.
Urologic Surgeons Begin Practice in Smilow Drs. John Colberg, Harris Foster, and Dinesh Singh are now seeing their patients on the fourth floor of Smilow Cancer Hospital. Their new phone number for scheduling patients is (203) 200-4822. |
Susan Silva has been hired in the Yale Cancer Center director's office as a senior administrative assistant. Susan joined the cancer center from the Yale School of Management and will support Kevin Vest, Chad Ellis, and Jennifer Mulligan. In the Clinical Trials Office, Vicky Marler joined the staff as a data manager for the GU team, Stephanie Sellers has been hired as a new data manager for the breast team, and Geraldine Tomassi has taken on the role of a Regulatory Assistant. Maureen Raucci, RN, BSN has been appointed to the Patient Service Manager position on NP 12. Maureen has been an assistant patient service manager on NP 12 for 2 years and has extensive management experience. She has led several important initiatives on NP 12 to improve patient outcomes and increase nursing satisfaction. Maeve G. Waldron-Lynch, Kamil Detyniecki, Maysa Abu-Khalaf, and Joachim Baehring are co-authors on a poster presented this week at the American Academy of Neurology Annual Meeting in Honolulu, Hawaii. The title of their presentation is A Single Institution Experience of Paraneoplastic Neurological Syndromes Associated with Gynecological Cancers. Tracy Carafeno, RN, MS has been chosen by the American Organization of Nurse Executives (AONE) as a nurse leader fellow for 2011. |
Funding and Award Opportunities Avon Foundation Breast Cancer Research Grants Proposals may request up to $150,000 total costs per year (this limit is inclusive of 10% indirect costs), for up to 2 years in duration. Thus, the total award budget can be up to $300,000 to cover up to 2 years duration. Priority Areas: - Understanding the potential causes of breast cancer and research to develop new preventative strategies
- Understanding the role of endogenous and exogenous environmental factors in the development of breast cancer
- Understanding whether viruses or infectious agents play a role in breast cancer
- Validation of markers/biomarkers of breast cancer risk or that signal different breast states such as parous vs. nulliparous breast (Note: we do not support discovery research. Our funds are directed towards validation, translation or clinical application of markers)
- Development of clinically applicable assays or diagnostic tests that are predictive of breast cancer risk or that can be used to monitor changes in breast over time (for example, differentiating healthy breast vs. ADH vs. DCIS vs. IDC)
- Understanding how parity and breastfeeding alter breast cancer risk
Letter of Intent Deadline: May 6, 2011 Learn More >> The Elsa U. Pardee Foundation The Elsa U. Pardee Foundation funds investigators proposing research directed toward identifying new treatments or cures for cancer. The foundation particularly encourages grant applications for a one-year period, which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early stage funding by the foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified. Learn More >> The V Foundation Translational Grant Yale Cancer Center has the opportunity to nominate a cancer research project that brings together pre-clinical and clinical investigators who are not currently funded together through an external grant. The purpose of the grant is to develop novel approaches to the prevention, detection and treatment of human cancer that requires collaboration of investigators from both the lab and clinic. The Translational Grant is a $600,000 award paid in $200,000 installments over three years. Please contact Roy Herbst if you have a project you would like considered for nomination. The V Foundation V Scholar Grant Yale Cancer Center can nominate one researcher for consideration for a V Scholar grant for laboratory based fundamental and translational research. Candidates must have completed two years of fellowship training but have not had more than five years on faculty, or ten years since terminal degree. The V Scholar grant totals $200,000 and is given in two yearly installments. Please contact Dan DiMaio to submit a nomination. 2011 Advanced Clinical Research Award in Breast Cancer funded by The Breast Cancer Research Foundation The grant is designed to fund investigators who are committed to clinical cancer research and who wish to conduct original research not currently funded. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Letter of Intent Deadline: May 3, 2011 Learn More >> Yale School of Public Health Ovarian Cancer Research Grant The Yale School of Public Health is pleased to announce a call for applications for the Ovarian Cancer Research Grant. This award is made possible by a generous gift from the Tina Brozman Foundation. The award is to provide funding for a pilot project in ovarian cancer prevention, detection, and survivorship research, which would ultimately lead to national peer-reviewed grants. Professors, Associate Professors, Assistant Professors, and Research Track faculty of all ranks are eligible to apply. There are no restrictions for citizenship. A one-year grant up to $25,000 will be awarded and will commence on July 1, 2011. Application Deadline: May 13, 2011 For more information, or to request an application, please email Yong Zhu. Connecticut Department of Public Health: Tobacco Use Cessation Programs The State of Connecticut, Department of Public Health (DPH) announces the release of a Request for Proposal (DPH RFP # 2011-0917) for tobacco use cessation services in Connecticut, especially targeting populations that have a documented disparate use of tobacco products compared to the general population. DPH is looking for contractors to provide group and individual tobacco use cessation counseling services to Connecticut residents. Letter of Intent Due: May 6, 2011 Learn More >>
The Donaghue Foundation Program for Research Leadership 2011 The Program for Research Leadership (PRL) is a Connecticut-focused grant program that will support transdisciplinary teams of health researchers led by a principal investigator who has demonstrated leadership in innovative and useful health research and in transferring knowledge gained from research into clinical and/or public health practice. The overall goal of the program is to fund rigorous health research that incorporates effective approaches to translating research knowledge into practice. The program provides opportunities for the team members to enhance their expertise in transdisciplinary work and knowledge translation. This is a four-year award granting up to $200,000 per year. Total grant award is up to $800,000 (plus 10% indirect costs on an annual basis). The foundation will make one Program for Research Leadership grant award in 2011. Letter of Intent Deadline: May 26, 2011 |
Cancer Survivors Day
Yale Cancer Center and Smilow Cancer Hospital will celebrate Cancer Survivors Day on Wednesday, May 25 on Yale's West Campus at 5 PM. The celebration will feature keynote speaker Ethan Zohn, winner of Survivor Africa and a cancer survivor. Following the program, guests will gather for a barbecue picnic. The planning committee would like to have entertainment during dinner. Please contact Emily Fentonif you know of a local band, or have a patient that participates in a musical group that may be willing to perform for a short set that evening.Thank you in advance for your help and suggestions. |
Clinical Trials Open for Accrual HIC 1012007786 Principal Investigator: Alessandro Santin Randomized Phase II Evaluation of Carboplatin/Paclitaxel with and without Trastuzumab (Herceptin) in HER2/neu+ Patients with Advanced/Recurrent Uterine Serous Papillary Carcinoma HIC 1012007806 Principal Investigator: Howard Hochster A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer (CALGB) (SWOG C80702)
HIC 1101007940 Principal Investigator: Mario SznolA Phase II Trial of GM-CSF Protein Plus Ipilimumab in Patients with Advanced Melanoma (ECOG E1608) |
Recent Publications
Physical Activity and Survival in Postmenopausal Women with Breast Cancer: Results from the Women's Health Initiative. Irwin ML, McTiernan A, Manson JE, Thomson CA, Sternfeld B, Stefanick ML, Wactawski-Wende J, Craft L, Lane D, Martin LW, Chlebowski R. Cancer Prev Res (Phila). 2011 Apr;4(4):522-9. Read More >>
MicroRNA therapeutics in preclinical cancer models. Kim M, Kasinski AL, Slack FJ. Lancet Oncol. 2011 Apr;12(4):319-21. Read More >> Self-Management and Transitions in Women with Advanced Breast Cancer. Schulman-Green D, Bradley EH, Knobf MT, Prigerson H, Digiovanna MP, McCorkle R. J Pain Symptom Manage. 2011 Mar 26. Read More >> High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. Varughese J, Cocco E, Bellone S, Bellone M, Todeschini P, Carrara L, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Gynecol Oncol. 2011 Mar 29. Read More >> A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. Paranjape T, Heneghan H, Lindner R, Keane FK, Hoffman A, Hollestelle A, Dorairaj J, Geyda K, Pelletier C, Nallur S, Martens JW, Hooning MJ, Kerin M, Zelterman D, Zhu Y, Tuck D, Harris L, Miller N, Slack F, Weidhaas J. Lancet Oncol. 2011 Apr;12(4):377-86. Epub 2011 Mar 22. Read More >> Vitamin D and Prevention of Cancer - Ready for Prime Time? Manson JE, Mayne ST, Clinton SK. N Engl J Med. 2011 Mar 23. Read More >>
Kilovoltage Imaging Doses in the Radiotherapy of Pediatric Cancer Patients. Deng J, Chen Z, Roberts KB, Nath R. Int J Radiat Oncol Biol Phys. 2011 Apr 6. Read More >> Neoadjuvant and Adjuvant Chemotherapy of Cervical Cancer: Mature Results of the Phase 2 PBM-PFU Protocol. McCaffrey R, Bahtiyar M, Kohorn EI, Chambers JT, Schwartz PE, Chambers SK. Int J Gynecol Cancer. 2011 Apr;21(3):535-44. Read More >>
Molecular markers of response to treatment for melanoma. Sznol M. Cancer J. 2011 Mar-Apr;17(2):127-33. Read More >> Molecular predictors of response to therapy for breast cancer. Galanina N, Bossuyt V, Harris LN. Cancer J. 2011 Mar-Apr;17(2):96-103. Read More >> Molecular tumor profiling for prediction of response to anticancer therapies. Walther Z, Sklar J. Cancer J. 2011 Mar-Apr;17(2):71-9. Read More >>
|
| |
| Countdown to the CCSG Submission 406 days until our CCSG grant
is due on May 25, 2012.
|
Join Yale Cancer Center on Facebook
|
Inside Yale Cancer Center
New Smoking Cessation Program Opens at Smilow Learn More >>
Read the April issue of Advances: Genetic Counseling Learn More >>
Read the Spring issue of Generations Learn More >>
In the News Read recent articles featuring experts from Yale Cancer Center Learn More >>
Subscribe to Yale Cancer Center Answers on iTunes
Yale Cancer Center's weekly radio program on CT Public Radio is ranked number 2 in the world for cancer programs on iTunes. Subscribe to the show.
Learn More >>
Cancer Bytes
Hosted by Ellen Matloff, listen to the latest interview with Nathan: Advanced Colon Cancer at age 21 - Not your Average College Experience. Learn More >>
Yale Cancer Center Grand Rounds
Video presentations from Yale Cancer Center members are now available online.
Learn More>>
DirectConnect Archives
Learn More >>
|
Events April 17; 6:00 PM Yale Cancer Center Answers WNPR High Risk Genetics Erin Hofstatter, MD Learn More >> April 18; 9:00 AM Yale Cancer Center Special Seminar SHM I-304 High Grade Non-Muscle Invasive Bladder Cancer: From Bedside to Bench James J. McKiernan, MD Learn More >> (PDF) April 18; 2:00 PM Yale Cancer Center Special Seminar WWW 201 Immunotransplant for Mantle Cell Lymphoma: Developing An Anti-Cancer Immune System Joshua Brody, MD Learn More >> (PDF)
April 19; 12:00 PM Yale Cancer Center Grand Rounds 55 Park Street Marie Curie and the 1911 Nobel Prize in Chemistry Sara Rockwell, PhD Immunotherapy with Biodegradable Nanomaterials Tarek Fahmy, PhD Learn More >> (PDF) April 20; 1:00 PM Cancer Immunology Seminar SHM B201 Regulation of Intestinal Tumorigenesis: Role of Inflammation, Cytokines, and Genetic Instability Alfred Bothwell, PhD Learn More >> (PDF) April 23; 6:00 PM Yale Cancer Center Answers WNPR Hematology Nikolai Podoltsev, PhD Learn More >> April 26; 12:00 PM Yale Cancer Center Grand Rounds 55 Park Street Iris Fischer Memorial Lecture Systemic Therapy for Early Stage Breast Cancer John Glick, MD Learn More >> (PDF) April 28; 9:00 AM Therapeutic Radiology Grand Rounds Smilow Cancer Hospital, lower level Understanding Overuse in Cancer Care Cary Gross, MD Learn More >> |
New Faculty Recruits (May 2009 - Present) Anees Chagpar Surgical Oncology Sandy Chang Lab Medicine Lieping Chen Immunobiology Deborah Chirnomas Pediatric Oncology Leonard Farber Medical Oncology Mark Faries Surgical Oncology Valentina Greco Genetics Stephanie Halene Hematology Roy Herbst Medical Oncology Howard Hochster Medical Oncology Erin Hofstatter Medical Oncology Nina Horowitz Surgical Oncology Michael Hurwitz Medical Oncology Benjamin Judson Otolaryngology Alfred Lee Hematology Arthur Levy Medical Oncology Miguel Materin Ophthalmology Daniel Morgensztern Medical Oncology Don Nguyen Pathology Abhijit Patel Therapeutic Radiology Nikolai Podoltsev Hematology Katie Politi Pathology Tara Sanft Medical Oncology Stacey Stein Medical Oncology Matthew Strout Hematology Narendra Wajapeyee Pathology Qin Yan Pathology |
Submissions Please submit your recent publication and grant announcements to: Renee Gaudette Director, Public Affairs and Marketing
renee.gaudette@yale.edu
|
| |
|
